Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden

NCT05238909 is registered in ClinicalTrials.gov with Ann & Robert H Lurie Children's Hospital of Chicago as lead sponsor.

NCT NCT05238909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05238909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 4, 2022
Completion date
June 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis 1, neurofibromatosis type 1, nf1